These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6343851)

  • 1. Studies on mutagenicity of 2 bronchodilators under development in Cuba.
    Jiménez MA; Torroella M; Fernández SI; Pellón R
    Mutat Res; 1983; 117(3-4):225-36. PubMed ID: 6343851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
    Suter W; Matter-Jaeger I
    Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of mutagenicity of trioxane and dioxolane in Salmonella typhimurium.
    Kowalski Z; Spiechowicz E; Barański B
    Mutat Res; 1984 Jun; 136(3):169-71. PubMed ID: 6377055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG; Paes DJ
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
    Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
    Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
    Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of flavones, chromones and acetophenones in Salmonella typhimurium. New structure-activity relationships.
    Elliger CA; Henika PR; MacGregor JT
    Mutat Res; 1984 Feb; 135(2):77-86. PubMed ID: 6363915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of 2-methylacrolein, 2-ethylacrolein and 2-propylacrolein in Salmonella typhimurium TA100. A comparative study.
    Neudecker T; Eder E; Deininger C; Henschler D
    Mutat Res; 1991 Dec; 264(4):193-6. PubMed ID: 1723498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity in Salmonella typhimurium TA98 of the serum extract of the organic matter derived from airborne particulates.
    Takeda N; Teranishi K; Hamada K
    Mutat Res; 1983 Apr; 117(1-2):41-6. PubMed ID: 6339909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
    Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
    Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic evaluation of the hair-dye component 2,4-diaminophenoxyethanol in Salmonella typhimurium/microsome plate test and Saccharomyces cerevisiae strains D4 and XV185-14C.
    Shahin MM; Bugaut A; Kalopissis G
    Mutat Res; 1982 Dec; 102(4):319-29. PubMed ID: 6757736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-mutagenicity of 3-dimethylamino-psi-saccharin to Salmonella typhimurium.
    Ashby J; Callander RD
    Cancer Lett; 1983 Jul; 19(3):343-5. PubMed ID: 6349789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic activity of 2-(2',4'-diaminophenoxy)ethanol in strains TA1538 and TA98 of Salmonella typhimurium.
    Mohn G; Bouter S; de Knijff P
    Mutat Res; 1982 Dec; 102(4):313-8. PubMed ID: 6757735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of cyclopenta-fused isomers of benz(a)anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites.
    Nesnow S; Leavitt S; Easterling R; Watts R; Toney SH; Claxton L; Sangaiah R; Toney GE; Wiley J; Fraher P
    Cancer Res; 1984 Nov; 44(11):4993-5003. PubMed ID: 6386146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
    Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
    Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of some organophosphorus compounds at the ade6 locus of Schizosaccharomyces pombe.
    Gilot-Delhalle J; Colizzi A; Moutschen J; Moutschen-Dahmen M
    Mutat Res; 1983 Apr; 117(1-2):139-48. PubMed ID: 6835257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of 7H-dibenzo[c,g]carbazole and metabolites in Salmonella typhimurium.
    Schoeny R; Warshawsky D
    Mutat Res; 1987 Aug; 188(4):275-86. PubMed ID: 3302697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.